Back
Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
REGN
Sponsored
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Buy
58
REGN
Regeneron Pharmaceuticals
Last Price:
903.51
Seasonality Move:
11.17%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the cornerRegeneron Pharmaceuticals Price Quote
$903.51
+12.92 (+1.45%)
(Updated: May 1, 2024 at 6:55 PM ET)
Regeneron Pharmaceuticals Key Stats
Buy
58
Regeneron Pharmaceuticals (REGN)
is a Buy
Day range:
$885.01 - $896.85
52-week range:
$684.81 - $998.33
Dividend yield:
0%
P/E ratio:
25.61
P/S ratio:
7.72
P/B ratio:
3.76%
Volume:
510K
Avg. volume:
438.8K
1-year change:
11.08%
Market cap:
$97.8B
Revenue:
$13.1B
EPS:
$34.75
How Much Does Regeneron Pharmaceuticals Make?
-
How Much Are Regeneron Pharmaceuticals's Sales Annually?
REGN Revenues are $13.1B -
How Much Profit Does Regeneron Pharmaceuticals's Make A Year?
REGN net income is $4B
Is Regeneron Pharmaceuticals Growing As A Company?
-
What Is Regeneron Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.01% -
What Is Regeneron Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.03%
Regeneron Pharmaceuticals Stock Price Performance
-
Did Regeneron Pharmaceuticals Stock Go Up Last Month?
Regeneron Pharmaceuticals share price went down by -7.47% last month -
Did REGN's Share Price Rise Over The Last Year?
REGN share price rose by 11.08% over the past 1 year
What Is Regeneron Pharmaceuticals 52-Week High & Low?
-
What Is Regeneron Pharmaceuticals’s 52-Week High Share Price?
Regeneron Pharmaceuticals has traded as high as $998.33 over the past 52 weeks -
What Is Regeneron Pharmaceuticals’s 52-Week Low Share Price?
Regeneron Pharmaceuticals has traded as low as $684.81 over the past 52 weeks
Regeneron Pharmaceuticals Price To Free Cash Flow
-
Is Regeneron Pharmaceuticals Stock Overvalued?
Regeneron Pharmaceuticals is trading at a price to free cash flow ratio of 27.62 -
Is Regeneron Pharmaceuticals Stock Undervalued?
Regeneron Pharmaceuticals EV to Free Cash Flow ratio is 24.24 -
What Is Regeneron Pharmaceuticals’s Price Earnings Growth Ratio?
REGN PEG ratio is 0.00 -
Is Regeneron Pharmaceuticals Trading At A Premium To Earnings?
Regeneron Pharmaceuticals EV to EBIT ratio is 20.81
Is It Risky To Buy Regeneron Pharmaceuticals?
-
How Much Debt Does Regeneron Pharmaceuticals Have?
Total long term debt quarterly is $2B -
How Much Cash Does Regeneron Pharmaceuticals Have?
Cash and short term investments quarterly total is $10.8B -
What Is Regeneron Pharmaceuticals’s Book Value Per Share?
Book value per share is 237.37
Is Regeneron Pharmaceuticals Cash Flow Positive?
-
What Is REGN Cash Flow From Operations?
Cash flow from operations (TTM) is $4.6B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.8B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$3.2B
Regeneron Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
REGN return on invested capital is 15.09% -
What Is Regeneron Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 12.74% -
What Is REGN Return On Equity?
ROE is a measure of profitability and is 16.33%
Regeneron Pharmaceuticals Earnings Date & Stock Price
-
What Is Regeneron Pharmaceuticals's Stock Price Today?
A single share of REGN can be purchased today for 890.59 -
What Is Regeneron Pharmaceuticals’s Stock Symbol?
Regeneron Pharmaceuticals trades on the S&P500 under the ticker symbol: REGN -
When Is Regeneron Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Regeneron Pharmaceuticals is scheduled on May 2, 2024 -
When Is REGN's next ex-dividend date?
Regeneron Pharmaceuticals's next ex-dividend date is May 2, 2024 -
How To Buy Regeneron Pharmaceuticals Stock?
You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Regeneron Pharmaceuticals Competitors
-
Who Are Regeneron Pharmaceuticals's Competitors?
Below is a list of companies who compete with Regeneron Pharmaceuticals or are related in some way:
Regeneron Pharmaceuticals Dividend Yield
Data Unavailable
Regeneron Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -2.95% | 10.37% |
Revenue: | 0.58% | 4.49% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 7 |
Sell Recommendations: | 0 |
Price Target: | 1,038.08 |
Upside from Last Price: | 16.56% |